

AEMP26 Abstract Session
Thursday, May 21, 2026 11:45 AM to 1:00 PM · 1 hr. 15 min. (America/New_York)
A602: Level A
AEMP26: Abstracts
Information
At the completion of this activity, the participant will be able to:
1. Interpret key findings from recent pharmacy-led research relevant to emergency medicine practice
2. Evaluate the methodology and clinical applicability of selected research abstracts
3. Assess the impact of emerging evidence on pharmacotherapy decision-making in acute care settings
1. Interpret key findings from recent pharmacy-led research relevant to emergency medicine practice
2. Evaluate the methodology and clinical applicability of selected research abstracts
3. Assess the impact of emerging evidence on pharmacotherapy decision-making in acute care settings
Ticketed Event
No
CPE
1.25
CME
0
Disclosures
Access the following link to view disclosures of session presenters, presenting authors, organizers, moderators, and planners:
AEMP26: Abstracts
When the Antidote Is Not Enough: Fomepizole’s Second Act in Acetaminophen Toxicity
Tuesday, May 19, 2026 3:15 PM to 5:20 PM
Atrium Ballroom B - C: Level A
Marianna Rieser · Memorial Regional Hospital
Evaluation of a Visual Aid on Calcium and Sodium Bicarbonate Use in Cardiac Arrest
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Zoe Dittmar · University of Iowa Health Care
Overnight Pharmacist Coverage and Time to Postintubation Sedation in the Emergency Department
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Kaitlyn Nichols · Hennepin Healthcare
Evaluation of Benzodiazepine Dosing in Status Epilepticus and Utilization of Adjunctive Treatments
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Brent Inouye · University of New Mexico
Hemorrhagic Transformation After Tenecteplase in Patients With Acute Ischemic Stroke: Outcomes of Reversal Therapy
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Vivian Kung · Memorial Hermann Hospital System
Efficacy and Safety of Desmopressin and Platelet Transfusions in Patients With Antiplatelet-Associated Intracranial Hemorrhage
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Hannah Moore · University of Louisville
No Time for Clots: Protocolizing Enoxaparin in Trauma Patients
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Sohniia Kaur · Novant Health Presbyterian Medical Center
Impact of Beta-Lactam Monotherapy on the Rate of Infection for Type III Open Fracture Prophylaxis
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Nicholas Sandusky · UofL Health
Safety and Hemodynamic Effects of Intravenous Labetalol for Acute Aortic Dissection in the Emergency Department
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Juan Garcia · Stanford Health Care-Sponsored Stanford University
Impact of Emergency Department Boarding on Delays in Second-Dose Antibiotic Administration
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Olivia Carroll · Froedtert and Medical College of Wisconsin
Characterization of Buprenorphine Utilization for Opioid Use Disorder in the Emergency Department
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Katie Thompson · NewYork-Presbyterian
Effect of Early Initiation of Oral Diltiazem Therapy on Time to Effective Heart Rate Control in Patients With Atrial Fibrillation or Atrial Flutter Treated With Intravenous Diltiazem
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Alivia Castle · University of Vermont Medical Center
Low-Dose Magnesium for Atrial Fibrillation With Rapid Ventricular Response in the Emergency Department
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Katelyn Skeeters · Medical University of South Carolina
Evaluation of a Subcutaneous Insulin Protocol for Management of Diabetic Ketoacidosis in the Emergency Department
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Hanson Hudgens · Northwestern Memorial Hospital
A Second Act: Fomepizole in Acetaminophen Toxicity
Thursday, May 21, 2026 11:45 AM to 1:00 PM
A602: Level A
Marianna Rieser · Memorial Regional Hospital
